Restricted accessResearch articleFirst published online 2022-08
How Does Human Milk Protect Against Necrotizing Enterocolitis (NEC)? Targeted Validation and Time-Course Analysis of 35 Gene Responses as NEC-Signature in Fetal Intestinal Epithelial Cells
Breastfeeding reduces the risk of necrotizing enterocolitis (NEC), one of the most common causes of morbidity and mortality in preterm infants. However, the molecular substrates by which human milk (HM) offers protection against NEC are not well known. Using fetal intestinal epithelial cells treated with known NEC aggravators, namely lipopolysaccharide (LPS) and platelet-activating factor (PAF), we mapped the time-course of changes in targeted expression analysis of 35 NEC-associated genes, so-called the NEC signature. We found, first, that HM treatment fully rescued LPS/PAF-induced fetal intestinal cell death at 12 and 24 h (n = 5). Differential gene expression and bioinformatics revealed that HM did not mitigate inflammatory and cell death signals, but instead promoted cell proliferation and stress response pathways to mitigate LPS/PAF-induced inflammatory cell death. From this, epidermal growth factor (EGF) synthesis emerged as the central player in rescue of the fetal intestinal cell death. Functional validation was supported by reversal of the cellular rescue by HM following EGF knockdown by small interfering RNA. In conclusion, this study suggests that HM might offer protection against NEC through enhancing intestinal EGF production to rescue the inflammatory cell death. Future studies are warranted to verify these HM molecular protective effects in NEC models in vivo. The findings reported herein also support future research avenues to discover new therapeutics to boost intrinsic EGF production in the injured intestinal tissues in neonates with NEC, for example, by bioactive components in human milk, natural compounds, or small molecules.
Get full access to this article
View all access options for this article.
References
1.
AlsaiedA, IslamN, ThalibL. Global incidence of necrotizing enterocolitis: A systematic review and meta-analysis. BMC Pediatr, 2020; 20:344.
2.
AlsaweedM, HartmannPE, GeddesDT, et al. MicroRNAs in breastmilk and the lactating breast: Potential immunoprotectors and developmental regulators for the infant and the mother. Int J Environ Res Public Health 2015; 12:13981–14020.
3.
AltobelliE, AngelettiPM, VerrottiA, et al.The impact of human milk on necrotizing enterocolitis: A systematic review and meta-analysis. Nutrients, 2020; 12:1322.
4.
AtesU, GolluG, KucukG, et al. Increase in pro-apoptotic Bax expression and decrease in anti-apoptotic Bcl-2 expression in newborns with necrotizing enterocolitis. Arch Argent Pediatr 2016; 114:243–247.
5.
BaregamianN, RychahouPG, HawkinsHK, et al. Phosphatidylinositol 3-kinase pathway regulates hypoxia-inducible factor-1 to protect from intestinal injury during necrotizing enterocolitis. Surgery 2007; 142:295–302.
6.
BaregamianN, SongJ, ChungDH. Effects of oxidative stress on intestinal type I insulin-like growth factor receptor expression. Eur J Pediatr Surg 2012; 22:097–104.
7.
BeinA, Eventov-FriedmanS, ArbellD, et al. Intestinal tight junctions are severely altered in NEC preterm neonates. Pediatr Neonatol 2018; 59:464–473.
8.
BeinA, ZilbershteinA, GolosovskyM, et al. LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol 2017; 232:381–390.
9.
CaplanMS, KellyA, HsuehW. Endotoxin and hypoxia-induced intestinal necrosis in rats: The role of platelet activating factor. Pediatr Res 1992; 31:428–434.
10.
ChanKYY, LeungFWL, LamHS, et al.Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants. PLoS One, 2012; 7:e36977.
11.
ChenG, LiY, SuY, et al. Identification of candidate genes for necrotizing enterocolitis based on microarray data. Gene 2018; 661:152–159.
12.
ChenY, KoikeY, ChiL, et al.Formula feeding and immature gut microcirculation promote intestinal hypoxia, leading to necrotizing enterocolitis. Dis Model Mech, 2019; 12:dmm040998.
13.
CorpeleijnWE, de WaardM, ChristmannV, et al. Effect of donor milk on severe infections and mortality in very low-birth-weight infants: The early nutrition study randomized clinical trial. JAMA Pediatr 2016; 170:654–661.
14.
CristofaloEA, SchanlerRJ, BlancoCL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013; 163:1592.e1–1595.e1.
15.
DvorakB, HalpernMD, HolubecH, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002; 282:G156–G164.
16.
GartnerLM, MortonJ, LawrenceRA, et al. Breastfeeding and the use of human milk. Pediatrics 2005; 115:496–506.
17.
GribarSC, SodhiCP, RichardsonWM, et al.Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol, 2009; 182:636.
18.
HalpernMD, HolubecH, DominguezJA, et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 2002; 51:733–739.
19.
HalpernMD, KhailovaL, Molla-HosseiniD, et al. Decreased development of necrotizing enterocolitis in IL-18-deficient mice. Am J Physiol Gastrointest Liver Physiol 2008; 294:G20–G26.
20.
HelmrathMA, ShinCE, FoxJW, et al. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 1998; 351:266–267.
21.
JungK, KohI, KimJH, et al. RNA-Seq for gene expression profiling of human necrotizing enterocolitis: A pilot study. J Korean Med Sci 2017; 32:817–824.
22.
KanaprachP, PongsakulN, ApiwattanakulN, et al. Evaluation of fetal intestinal cell growth and antimicrobial biofunctionalities of donor human milk after preparative processes. Breastfeed Med 2018; 13:215–220.
23.
MihiB, GoodM. Impact of Toll-like receptor 4 signaling in necrotizing enterocolitis: The state of the science. Clin Perinatol 2019; 46:145–157.
24.
MillerJ, TonkinE, DamarellRA, et al.A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients, 2018; 10:707.
25.
NolanLS, ParksOB, GoodM. A review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis. Nutrients, 2019; 12:14.
26.
PongsakulN, KanaprachP, ChiangjongW, et al. Fetal intestinal cell growth as a measure of the comparative biofunctionality of human milk and infant formulas: An in vitro study. Breastfeed Med 2018; 13:510–515.
27.
RabaAA, O'SullivanA, MiletinJ. Pathogenesis of necrotising enterocolitis: The impact of the altered gut microbiota and antibiotic exposure in preterm infants. Acta Paediatr 2021; 110:433–440.
28.
RusconiB, JiangX, SidhuR, et al.Gut sphingolipid composition as a prelude to necrotizing enterocolitis. Sci Rep, 2018; 8:10984.
29.
SeoS, MiyakeH, AlganabiM, et al. Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis. J Pediatr Surg 2019; 54:2520–2523.
30.
SharmaR, TepasJJ, 3rd, HudakML, et al. Neonatal gut barrier and multiple organ failure: Role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007; 42:454–461.
31.
ShelbyRD, CromeensB, RagerTM, et al. Influence of growth factors on the development of necrotizing enterocolitis. Clin Perinatol 2019; 46:51–64.
32.
ShinCE, FalconeRAJr., StuartL, et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000; 35:173–177.
33.
SiggersRH, SiggersJ, ThymannT, et al. Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis. J Nutr Biochem 2011; 22:511–521.
34.
SodhiCP, ShiXH, RichardsonWM, et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 2010; 138:185–196.
35.
SolimanA, MichelsenKS, KarahashiH, et al.Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: Implication for the pathogenesis of necrotizing enterocolitis. PLoS One, 2010; 5:e15044.
36.
StefanuttiG, ListerP, SmithVV, et al. P-selectin expression, neutrophil infiltration, and histologic injury in neonates with necrotizing enterocolitis. J Pediatr Surg 2005; 40, 942–948.
37.
SullivanPB, LewindonPJ, ChengC, et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1–48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 2007; 42:462–469.
38.
SullivanS, SchanlerRJ, KimJH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156:562.e1–567.e1.
39.
SzklarczykD, GableAL, LyonD, et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019; 47:D607–D613.
40.
TakahashiT, ShiraishiA. Stem cell signaling pathways in the small intestine. Int J Mol Sci, 2020; 21:2032.
41.
WangC, ZhangM, GuoH, et al. Human milk oligosaccharides activate epidermal growth factor receptor and protect against hypoxia-induced injuries in the mouse intestinal epithelium and Caco2 cells. J Nutr 2020; 150:756–762.
42.
WertsAD, FultonWB, LaddMR, et al. A novel role for necroptosis in the pathogenesis of necrotizing enterocolitis. Cell Mol Gastroenterol Hepatol 2020; 9:403–423.
43.
World Health Organization. Guidelines on Optimal Feeding of Low Birth-Weight Infants in Low- and Middle-Income Countries. World Health Organization: Geneva; 2011.
44.
XuJ, TreemWR, RomanC, et al. Ileal immune dysregulation in necrotizing enterocolitis: Role of CD40/CD40L in the pathogenesis of disease. J Pediatr Gastroenterol Nutr 2011; 52:140–146.
45.
YiDY, KimSY. Human breast milk composition and function in human health: From nutritional components to microbiome and microRNAs. Nutrients, 2021; 13:3094.
46.
YinY, LiuF, LiY, et al. mRNA expression of TLR4, TLR9 and NF-κB in a neonatal murine model of necrotizing enterocolitis. Mol Med Rep 2016; 14:1953–1956.
47.
YinY, WangJ, ZhaoX, et al.Overexpressed FOXO3 improves inflammatory status in mice by affecting NLRP3-mediated cell coronation in necrotizing colitis mice. Biomed Pharmacother, 2020; 125:109867.
48.
YuanY, DingD, ZhangN, et al. TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6. Cell Cycle 2018; 17:1390–1402.
49.
ZamoraR, VodovotzY, BettenB, et al. Intestinal and hepatic expression of BNIP3 in necrotizing enterocolitis: Regulation by nitric oxide and peroxynitrite. Am J Physiol Gastrointest Liver Physiol 2005; 289:G822–G830.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
